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Essential oils (EOs) and their main constituents, the terpenes, are widely studied,
mostly relating to their antioxidant ability and bioactivity, such as antimicrobial,
anticancer, anti-inflammatory, and range of other actions in the living systems.
However, there is limited information on their bioavailability, especially upon clinical
studies. Having in mind both strong biological effects and health benefits of EOs
and their specific physicochemical properties (volatility, lipophilic character, low water
solubility or insolubility, viscosity, expressed odor, concentration-dependent toxicity,
etc.), there is a need for their encapsulation for target delivery. Encapsulation of
EOs and their constituents is the prerequisite for enhancing their oxidative stability,
thermostability, photostability, shelf life, and biological activity. We considered various
carrier types such a (1) monophase and polyphase polysaccharide hydrogel carriers, (2)
polysaccharide–protein carriers, and (3) lipid carriers in the context of physicochemical
and engineering factors. Physicochemical factors are encapsulation efficiency, chemical
stability under gastric conditions, mechanical stability, and thermal stability of carrier
matrices. Choice of carrier material also determines the encapsulation technique.
Consequently, the engineering factors are related to the advantage and disadvantage
of various encapsulation techniques frequently used in the literature. In addition,
it was intended to address the interactions between (1) main carrier components,
such as polysaccharides, proteins, and lipids themselves (in order to form chemically
and mechanically stable structure); (2) main carrier components with pepsin under
gastric conditions (in order to form resistant material under gastric conditions); and
(3) main carrier components with EOs (in order to enhance encapsulation efficiency),
as a necessary precondition for whole process optimization. Finally, different sources
for obtaining natural carrier macromolecules are surveyed, especially the agro-waste
materials and agricultural and food by-products. This review article highlights the
bioavailability aspects of encapsulated EOs and physicochemical and engineering factors
concerning natural macromolecule carriers for their target delivery and application.
Keywords: bioavailability, matrix material, isoprenoids, capsulation, gastric digestion, reuse
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INTRODUCTION
It is assumed that ∼80% of the world’s population relies on
plant-based products in official and traditional medicine, where
plant products make approximately one-quarter of the total
pharmaceutical arsenal (Bhattaram et al., 2002). In addition,
plant bioactive compounds are widely applied in pharmaceutics
industry, cosmetics, food industry, and recently as fine (agro)
chemicals and nutraceuticals (Bourgaud et al., 2001).
The isoprenoids are known as the largest family of plant
bioactive compounds, participating in the composition of plant
essential oils (EOs) in various combinations. Encapsulation
of EO is a prerequisite for applying EOs because of some
of their properties, such as volatility, intense odor and taste,
dose-dependent toxicity, and very high biological activity. The
encapsulation also prevents the EOs from degradation and
transformation under digestion and protects the body from
undesirable effects of EOs (Maderuelo et al., 2019). Moreover,
entrapping of EOs enhances their bioavailability. Development
of various techniques of encapsulation ensures wide use of EOs
in pharmaceutical industry (e.g., Asbahani et al., 2015; Pandit
et al., 2016; Arpagaus et al., 2018) and cosmetics (e.g., Martins
et al., 2014; Carvalho et al., 2016). Engineering optimization of
delivery process as a whole includes several interconnected steps:
(1) choice of carrier matrix with best performances in accordance
with particular delivery conditions, (2) ensuring the maximum of
encapsulation efficiency, and (3) consideration of the reuse ability
for carrier matrix components, such as natural polysaccharides
and proteins. Polysaccharides, such as pectin, inulin, starch,
cellulose, and hemicelluloses, are widely used in the form of
single hydrogels as well as their blends. These macromolecules
can be extracted from wastes of vegetable industrial processing
by applying various chemical or enzymatic techniques (Poli et al.,
2011). Polysaccharide hydrogels have been mixed with natural
proteins, such as soy proteins, whey proteins, lecithin, and
some others, in order to improve their chemical stability under
gastric conditions for various biomedical and biotechnological
applications, including EO encapsulation (Volić et al., 2018;
Obradovic et al., 2019).
The present article aims to review the most important
groups of natural macromolecules used in entrapping of EOs
in relation to the general physicochemical properties of EOs
and their constituents. Our intention was also to elaborate the
aspects of bioavailability and biological behavior under different
administration modes, which significantly depends on the choice
of carrier matrix. Performances of various carrier matrices are
discussed in the context of (1) preparation procedures and
(2) their mechanical and chemical stabilities under in vivo
process conditions. The preparation procedure accounts for
using various natural polysaccharides and proteins in the form of
composite hydrogel matrices previously extracted from agri-food
by-products. On that way, whole cycle from waste materials to
various biomedical applications is elaborated on some examples
in order to point out the complexity of this task. The starting
point in such a complex procedure of optimization of the carrier
system and encapsulation process is the characterization of
bioactive core material, primarily the physicochemical features
and biological behavior, as well as the application of the




Definition of International Organization for Standardization
(ISO) indicates that EOs are products obtained from vegetable
raw material by physical processes of distillation or pressing.
The plant volatiles are typical products of aromatic plants that
have been already recorded in 1,618 plant species, subspecies,
or varieties representing 92 plant families according to the
EssOilDB database (Kumari et al., 2014). Essential oils are
complex mixtures containing mostly volatile organic compounds
(VOCs) synthesized and emitted by plants in order to facilitate
their growth and survival (Loreto et al., 2014). Besides VOC,
EOs contain also different degradation products formed in
enzymatic, chemical, or physical processes. The typical example
is chamazulene formed by the breakdown of matricine during
the steam distillation (Clarke, 2008). The other example is
khusimone, nor-patchoulenol, or nor-tetrapatchoulol containing
only 14 carbon atoms, and all formed from sesquiterpenoids
(Baser and Buchbauer, 2010). Essential oils are mixtures of
low-molecular-weight compounds (usually below 300 Da) and
can be composed from more than a dozen, even to 300
molecules, which usually belong to 5 to 10 distinct chemical
classes or congeneric groups. The content of single constituent
or a congeneric group of constituents in the EOs may
vary from hundredths of a percent to several dozen percent
(Baser and Buchbauer, 2010; Dhifi et al., 2017).
Constituents of EOs derive from three plant biosynthetic
pathways yielding isoprenoids, phenylpropanoids, and
polyketides and lipids (Dudareva et al., 2006; Baser and
Buchbauer, 2010; Moghaddam and Mehdizadeh, 2017).
Glucose formed from carbon dioxide and water is transformed
into phosphoenolpyruvate involved in the formation of
phenylpropanoids (shikimates) via L-phenylalanine. The same
structure of phosphoenolpyruvate after decarboxylation gives
acetate, which esterifies with coenzyme-A and gives the acetyl-
CoA. Polyketides and lipids are the result of self-condensation of
acetyl-CoA. Acetyl-CoA, used as well for formation of mevalonic
acid, gives rise to isoprenoids (Baser and Buchbauer, 2010). The
other constituents of EOs are derivatives of amino acids other
than L-phenylalanine (Dudareva et al., 2006).
Isoprenoids
Isoprenoids (terpenes) are formed by coupling of isoprene (2-
methylbutadiene) units in a pattern called head-to-tail joining,
and their structure contains a multiple of five carbon atoms
(Mann et al., 1994; Baser and Buchbauer, 2010). Hence, the
structural classification of terpenes is based on the number
of isoprene units in a molecule. Hemiterpenes are built from
one isoprene unit (C5); monoterpenes contain 10 carbons
(C10), and sesquiterpenes contain 15 (C15), whereas diterpenes
contain 20 (C20). Functional characterization depends on
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FIGURE 1 | Successive steps and their interrelations in selection and optimization of carrier system for EO encapsulation.
cyclic or linear structure, degrees of unsaturation, or type of
substituents (hydrocarbons, alcohols, ethers, oxides, aldehydes,
ketones, esters). The term terpenoids is restricted to isoprenoids
bearing oxygenmoiety (Baser and Buchbauer, 2010;Moghaddam
and Mehdizadeh, 2017). Some molecules presented in EOs
are the degradation products of larger, usually not volatile
structures. Norisoprenoids are degradation products resulting
from the enzymatic or non-enzymatic cleavage of triterpenoids or
tetraterpenoids. Ionones, damascones, or megastigmanes result
from degradation of the central part of the chain of carotenoids,
whereas irones are the degradation products of triterpenoid
iripallidal (Fleischmann and Zorn, 2008; Baser and Buchbauer,
2010).
Phenylpropanoids
The basic structure in shikimate derivatives is C6–C3 unit of
benzene ring (C6) linked usually to three-carbon side chain (C3)
at position 1 and oxygenated in the third/fourth/fifth position/s.
C3 often possess a carbon–carbon double bond; however, the
side chain can also be shortened to one carbon (C1). Phenols
or phenol ethers are phenylpropanoids frequently found in EOs
(Baser and Buchbauer, 2010; Moghaddam and Mehdizadeh,
2017).
Derivatives of Polyketides and Lipids
Fatty acid derivatives found in EO are formed in condensation
reactions of polyketides, degradation of lipids or cyclization
of arachidonic acid (Dudareva et al., 2006). Condensation of
polyketides results in formation of phenolic rings, which are
oxidized on alternate carbon atoms, either as acids, ketones,
phenols, or as one end of a double bond (Baser and Buchbauer,
2010). The array of enzymatic reactions on fatty acids, such
as cleavage, oxidation, lactonization, reduction, or elimination,
gives rise to short-chain lactones, alcohols, or aldehydes,
whereas cyclization or arachidonic acid results in production of
prostaglandins and jasmonates (Dudareva et al., 2006; Baser and
Buchbauer, 2010).
Derivatives of Amino Acids Other Than
l-Phenylalanine
Amino acids, such as alanine, valine, leucine, isoleucine, and
methionine, are the precursors of aldehydes, alcohols, esters,
acids, and nitrogen- and sulfur-containing constituents of
EOs (Dudareva et al., 2006). Sulfur compounds (sulfides,
disulfides, trisulfides, sulfoxides, and isothiocyanates), as well
as heterocyclic compounds containing nitrogen (indole, methyl
anthranilates, pyridines, and pyrazines) or oxygen (lactones,
coumarins, and furanoids) in a ring, are rarely found in EOs.
These molecules have relatively simple structures and intensive
characteristic or pungent odor (Moghaddam and Mehdizadeh,
2017). Some examples of the main groups of EO constituents are
presented in Figure 2.
Physical Characteristics of EOs
The basic characteristic of EOs is their odor. Constituents
of EOs are partly in the vapor state due to high vapor
pressure at atmospheric pressure and at room temperature
(Dhifi et al., 2017). Higher number of carbon atoms in the
structure results in decreased volatility. The highest boiling
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FIGURE 2 | Examples of different groups of EO constituents.
points have monoterpenes; hence, compounds from this class
are highly volatile and evaporate quickly. Sesquiterpenes
are still sufficiently volatile to be present as EOs; however,
diterenes are less frequently found in volatile fractions
(Baser and Buchbauer, 2010).
The distillation of plant material usually yields a transparent,
colorless, or pale yellow liquid, immiscible with water and
having density lower than water. However, some exceptions are
known. Solid or semisolid EOs are obtained from orris and
guaiac wood or plumeria, respectively. Chamomile gives blue
EO; and European valerian, green; and vetiver, brown, whereas
cinnamon gives yellow to brownish. Cinnamon, sassafras, and
vetiver EOs have density equal to or near one, relative to water
(Dhifi et al., 2017; Moghaddam andMehdizadeh, 2017). Essential
oils are soluble in fats, alcohols, and most organic solvents.
Their constituents contain asymmetric carbons, what results in
optical activity (optical rotation). They are also characterized by
refractive index (Moghaddam and Mehdizadeh, 2017). Density,
optical rotation, and refractive index are the parameters used to
control quality of EOs. Their correct determination is described
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in standards published by ISO1 (ISO/TC 54: ISO 279:1998; ISO
280:1998; ISO 592:1998), and the range of acceptable values is
provided for most commercially available EO. Basic physical
characteristics of some terpene compounds and EOs are provided
in Tables 1, 2, respectively.
Stability of EOs
During release from plant structures (ducts or glands),
volatiles become susceptible to temperature, light, oxidation,
or hydrolysis. The final composition of EOs depends not
only on chemical composition of plant material, but also on
plant material processing and storage, distillation processes,
and subsequent handling of EOs (Turek and Stintzing, 2013;
Moghaddam and Mehdizadeh, 2017). The major factor
influencing stability of EOs is the chemical character of their
constituents. Compounds containing double bonds are prone
to autoxidation because hydrogen atom abstraction results
in resonance-stabilized radicals. Polyunsaturated terpenic
hydrocarbons can form radicals stabilized by conjugated
double-bonds. At the same time, isomerization to tertiary
radicals can take place, leading to oxidative deterioration (Turek
and Stintzing, 2013). The access to aerial oxygen causes the
spontaneous free radical chain reactions, resulting in production
of unstable hydroperoxides, which decompose in the presence of
light, heat, or upon increasing acidity. Monovalent to polyvalent
alcohols, aldehydes, ketones, epoxides, peroxides, acids, or
oxygen-bearing polymers are stable secondary oxidation
products. Some oxygen-bearing terpenoids are, however,
directly converted into oxidized secondary products without
hydroperoxides formation (Geier, 2006; Turek and Stintzing,
2013). Because the oxygen present in headspace diffuses into the
sample over storage time, the EOs should be kept in completely
filled containers or, if possible, should be treated with inert
gas to remove remaining air and prevent oxidative reactions
(Geier, 2006; Turek et al., 2012). The two other factors strictly
correlated with oxidative deterioration of EOs are light and
temperature. Light accelerates autoxidation and formation of
alkyl radicals, catalyzes intramolecular isomerization reactions
or trans–cis conversions in monoterpenes, and increases the
degradation of monoterpenes (Turek and Stintzing, 2013). Heat
accelerates chemical reactions and contributes to formation
of primary auto-oxidation products—hydroperoxides, which
are subsequently decomposed with increasing temperature,
resulting in final oxidation products (Turek and Stintzing,
2012, 2013; Turek et al., 2012). Volatiles are thermolabile and
susceptible to rearrangement processes at elevated temperatures.
Thermal degradation of terpenes is classified into four types
of oxidative reactions: cleavage of double bonds, epoxidation,
dehydrogenation into aromatic systems, and allylic oxidation
into alcohols, ketones, and aldehydes (McGraw et al., 1999).
Because oxygen solubility is lower at elevated temperatures, alkyl
or hydroxyl radical formation is more pronounced. On the other
hand, storage of EOs at low temperatures favors the solubility of
oxygen in liquids and results in peroxide formation (Turek and
Stintzing, 2013). In complex mixtures, such as EOs, compounds
1ISO 9235:2013(en) Aromatic natural raw materials—Vocabulary.
easily undergo oxidation, predominantly isoprenoids, affecting
more stable structures initiating their rearrangement and
decomposition reactions. In return, phenylpropanoids present
as EOs act as antioxidants able to scavenge free radicals and to
protect other molecules from deterioration (Turek and Stintzing,
2013). As a result of decomposition processes described above,
EOs are losing their quality. The most evident signs of aging are
changes in colors, consistency, and odor, and at the last being as
unpleasant and often pungent.
General physicochemical features of EOs (complexity and
interactions of individual compounds) and their constituents
(low molecular weight, presence of different functional groups in
the molecule, reactivity, and hydrophobicity) strongly affect the
biological activity of EOs.
BIOAVAILABILITY OF EOs
Essential oils and/or their already extracted individual
compounds are well-characterized primarily in the context
of their strong antimicrobial (e.g., Burt, 2004; Nazzaro et al.,
2013; Semeniuc et al., 2017) and antioxidant activity (e.g.,
Miguel, 2010). The antimicrobial effects of EOs are connected
to their ability to penetrate through bacterial cell wall, where
disruption of the bacterial wall induces leakage of ions, reduction
of membrane potential, disruption of membrane enzymes,
and alterations in structural and functional properties of
bacterial cell (Edris, 2007). The EO compounds have strong
antioxidant capacity linked to their H-donating properties,
ability to inhibit lipid autoxidation, the quenching of singlet
oxygen, hydrogen transfer, or electron transfer (e.g., Grassmann,
2005). Besides these effects, EOs are much studied for their
anticancer (e.g., Bayala et al., 2014), anti-inflammatory (Sá et al.,
2014), anxiolytic (De Sousa, 2012), analgesic-like (De Sousa,
2011), antinociceptive (Lenardão et al., 2016), and antiaging and
neuroprotective effects (Ayaz et al., 2017). Complex and various
bioactive roles of EOs and their compounds were summarized
in several comprehensive reports (e.g., Edris, 2007; Bakkali et al.,
2008; Raut and Karuppayil, 2014; Sarkic and Stappen, 2018).
However, the behavior of EOs and their individual compounds
in human body upon administration is far less revealed.
The term bioavailability refers to pharmacokinetic properties
of the drug after reaching the systemic circulation allowing its
actions at the target sites (Stahl et al., 2002). Bioavailability, in
fact, includes two interconnected subsets: the bioaccessibility and
the bioactivity. The concept of bioaccessibility is defined as the
quantity or fraction that is released from the food matrix in
the gastrointestinal tract being available for absorption (Thakur
et al., 2020). It also describes the availability of compound
for assimilation after digestive transformations, the absorption,
and, finally, the presystemic intestinal and hepatic metabolism
(Cardoso et al., 2015). The concept of bioactivity includes
the processes of drug entering into systemic circulation, its
transportation to the target site, and interactions with different
biomolecules, resulting in expression of various metabolic and
physiological effects (Wood, 2005; Carbonell-Capella et al.,
2014). Bioavailability is the key aspect for assessment of









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































drug absorption applied via different administration routes
(Maderuelo et al., 2019).
Approaches in Bioavailability Studies
Bioavailability and bioaccessibility of plant metabolites, including
EOs and their individual terpene compounds, are studied by
different in vivo and in vitro methods. In vitro digestion
models are commonly used for bioaccessibility estimation.
The most of these methods simulate the conditions of
gastrointestinal (GI) system by adjusting the pH and introduction
of particular digestive enzymes (e.g., salivary amylase, pepsin,
gastric lipase, trypsin, chymotripsin, pancreatic lipase, etc.),
bile salts, and, sometimes involving fermentation reactions to
reproduce the colon performance (Jones et al., 2019). Recent in
vitro bioaccessibility/bioavailability studies include cell models,
primarily Caco-2 cells isolated from the human colorectal
adenocarcinoma, where absorbed target compound is collected
on the basolateral side of the monolayer model cells (Jones et al.,
2019; Thakur et al., 2020). Bioavailability studies have been also
performed by in vivo animal and clinical studies.
As for the other drugs, bioavailability of EOs and their
compounds represents the concentration threshold reaching the
blood circulation system and includes digestion (in case of
oral administration), absorption, transformation (metabolism),
tissue distribution, and bioactive performance at the target sites
(Carbonell-Capella et al., 2014).
Bioavailability comprises pharmacodynamic and
pharmacokinetic performances of bioactive compounds.
Pharmacodynamics of EOs includes effects of their individual
compounds on human and animal biochemical and physiological
processes, i.e., should include the monitoring of biological
activity at target organs, tissues, and cells. Independently of
low selectivity of EOs, their bioactive effects are expressed after
reaching the blood circulation.
Pharmacokinetics of EOs in fact reflects the destiny of each
individual compound from the intake toward final elimination
from the body, referring different processes of bioaccessibility
and bioavailability.
The primary intake routes of EOs are skin application,
inhalation, and oral intake.
Bioavailability of EOs in Relation of
Administration Routes and EO Absorption
Various factors affect the bioavailability of EOs, such as
physiochemical, biochemical, and physiological interactions. The
comprehension of bioavailability of EOs includes the monitoring
of successive phases of their absorption, distribution, and
excretion in the human body. There is limited information
on their behavior and fate in human, and most studies are
performed either in vitro (e.g., Volić et al., 2018) or on
animal models (e.g., Michiels et al., 2008; Zhang Y. et al.,
2014). It is assumed that bioavailability of EOs is maximal
(100%) by intravenous administration and decreases upon
other administration routes. However, the bioavailability of EO
constituents orally administrated might be very high, as reported
for 1,8-cineole with bioavailability rate of 95.6% (Zimmermann
et al., 1995).
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TABLE 2 | Physical characterization of selected essential oils.









Colorless to pale yellow-greenish
liquid with Strong peppermint
odor and sweet, balsamic taste,
often masked by the distinct
cooling effect














Dark yellow clear oily liquid with
sweet spicy aldehydic aromatic
cinnamyl woody resinous honey
powdery odor


















Thyme essential oil Colorless clear liquid with herbal,
phenolic odor
Soluble in 70% ethanol at
20◦C
0.941 at 25◦C 1.506 at
20◦C/D





Cumin essential oil Light yellow to brown liquid with
strong, somewhat fatty and
green odor
Soluble in 80% ethanol at
20◦C; Soluble in fixed oils,























Colorless or pale yellow liquid
with odor and taste of nutmeg
Soluble in fixed oils, mineral
oil; slightly soluble in cold
alcohol; very soluble in hot
alcohol, chloroform, ether;
insoluble in glycerine,











Nevertheless, recent reports confirm thatmost EOs are rapidly
absorbed under dermal, oral, or pulmonary administration. To
assume the bioavailability and especially the bioactivity of EOs,
it is necessary to know how and in which amount they could
enter the blood circulation and how they are distributed within
the body, all reflecting the safety issues of EOs (Tisserand and
Young, 2014).
Dermal Administration
The skin consists of outer and deeper dermis, where the stratum
corneum, the outer epidermis layer, is the first physical barrier for
penetration of external chemicals (Godin and Touitou, 2007). It is
assumed that there are three possible skin penetration pathways:
the intercellular (between the skin cells), the transcellular
(through the cells), and the route through the hair follicles,
bypassing the stratum corneum (Williams and Barry, 2012). It is
already known thatmost of EOs’ constituents penetrate from skin
surface and through the stratum corneum, toward the dermis,
and finally into the blood circulation (Tisserand and Young,
2014). Regarding lipophilic feature of EOs, the high percutaneous
absorption rates should be considered in risk assessments in
systemic toxicity.
Hydrophilic drugs are better absorbed in combination with
terpenes containing polar functional groups, and similarly, the
absorption of lipophilic compounds is improved in the presence
of hydrocarbon terpenes (Godwin and Michniak, 1999). In
general, lipophilic drugs pass the dermal barrier more intensively
than the hydrophilic substances (Wester and Maibach, 2000).
Terpene compounds are also used for the improvement of
the transdermal drug delivery (Aqil et al., 2007), mainly due
to high percutaneous enhancement ability and low cutaneous
irritancy at concentrations of <5% (Nokhodchi et al., 2007). In
addition, EOs are known for their positive effects on skin and
prevention and healing of some dermatological disorders (e.g.,
Sarkic and Stappen, 2018). There are recent applications of EOs
encapsulated by liposomes in cosmetics (Sherry et al., 2013).
Respiratory Administration
Inhaled substances are transported via trachea into the bronchi
and then to bronchioles and finally toward lung alveoli, which
are very efficient in transporting small molecules, such as
terpenes, into the blood circulation (Tisserand and Young, 2014).
Beneficial effects of EOs on respiratory system by inhalation are
well-accepted (e.g., Maddocks-Jennings and Wilkinson, 2004).
Rectal and Vaginal Administration
Rectal suppositories are used in the case when high systemic
concentrations are desired for bioactivity in the colon. However,
dosage and concentrations should be carefully adjusted because
of the high sensitivity of rectal mucous membrane for EOs
and possible irritations (Tisserand and Young, 2014). Similar
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finding refers to the vaginal application of EOs, where
additional emulsification is required. It might be expected
that encapsulation of EOs with adequate carriers for these
applications will be developed in future experiments.
Oral Administration
Oral administration of free EOs is generally performed by
dilution with milk, soy milk, olive oil (Bilia et al., 2014), or other
vegetable oils. However, oral intake is the most common way
in application of encapsulated EOs, especially in case of food
supplements and functional foods. Entrapping of EOs and/or
their already extracted individual bioactive compounds (e.g.,
menthol, chamazulene, thymol, carvacrol, limonene, 1,8-cineole,
etc.) enables targeting and controlled release of EOs, protects EOs
from degradation and losses, and allows masking of unpleasant
taste and odor (e.g., Bilia et al., 2014; Asbahani et al., 2015;
Dajić Stevanović et al., 2018) via oral intake. Bioavailability
of the matrix and EO components is complex and should be
considered from the aspect of stability of microencapsulated
or nanoencapsulated carriers within the GI tract, as well as
enhanced bioavailability and, particularly, the systemic activity of
a drug at the action site.
Gastrointestinal tract is tube-like of interconnected
compartments containing associated organs, such as liver,
pancreas, and gallbladder. The upper GI tract is composed of
the oral cavity and salivary glands, the esophagus, stomach,
and small intestine (duodenum, jejunum, and ileum), whereas
the lower GI tract is represented by the large intestine (cecum,
colon, and rectum) (Treuting et al., 2018). The GI tract is
enveloped by four concentric layers: the innermost mucous
layer, with the presence of mucus and HCl secreting glands; a
submucosal layer; and the outer muscular and the outermost
serous layers (Maderuelo et al., 2019). The principal risk of
administering of EOs or their constituents to any part of
the GI tract is irritation and inflammation of the mucous
membrane whose irritation is highly concentration-dependent
(Tisserand and Young, 2014). Nevertheless, many reports
highlighted the beneficial effects of EOs and their compounds
on gastric mucosa, where gastroprotective activity was associated
with different mechanisms, such as activation of a2-receptors,
increased HSP-70, VIP, and PGE2 expression (heat shock protein,
vasoactive intestinal peptide, and prostaglandin, respectively),
and gastric SH group bioavailability (Rozza and Pellizzon, 2013).
According to Fernandes et al. (2012), the lemongrass EO reduces
gastric damage due to mechanisms involving endogenous
prostaglandins, while gastroprotective action of orange EO
and the limonene is related to an increase in the gastric mucus
production (Moraes et al., 2009). Therefore, in some cases, it is
reasonable to ensure the complete release of EO from coating
material in the stomach due to positive effects on bioactive
compounds on the gastric mucosa.
Besides responsibility for digestion due to low gastric pH
and enzymatic activity of pepsin, the stomach allows absorption
of water and some substances, including some particular
terpenes (which should be less lipophilic, i.e., those containing
polar groups, such as oxygenated monoterpenes, such as
linalool, geraniol, neral, thymol, citronellol, etc.). In experiments
performed through in vitro conditions and in vivo on piglets
model, it was shown that thymol, eugenol, carvacrol, and trans-
cinnamaldehyde were weakly degraded in the proximal segments
of the GI piglet tract under in vitro conditions. In vivo studies
showed that these EO constituents were almost completely
absorbed in the upper GI tract, by the stomach and the proximal
small intestine (Michiels et al., 2008). Digestive enzymes can
break down some types of EO constituents; for example, esters
may be hydrolyzed in the stomach (Tisserand and Young, 2014).
The intestine as the main absorption site is characterized
by high absorption area due to the presence of villi and
microvilli. The absorption rate of EOs constituents highly
depends on some factors, such as molecular weight, lipophilicity,
solubility, and polarity (Esfanjani et al., 2018). Therefore,
different terpenes are absorbed at different rates and by different
parts of the GI tract. It was shown that the upper GI tract
is not responsible for absorption of 1,8-cineole (Kohlert et al.,
2000), in contrary to the fast absorption of thymol (Kohlert
et al., 2002), confirming former results with ileostomy patients
(Somerville et al., 1984). The rapid absorption of terpenes was
confirmed by detection of 1,8-cineole and α-pinene in plasma
just after 30min after oral application (Zimmermann et al.,
1995). Mixing of EO components with pancreatic juice and bile
salts in duodenum would result in their better solubilization
and related rapid absorption (Michiels et al., 2008). The fast
absorption of EO compounds is attributed to their small size
and lipophilic nature (Kohlert et al., 2002). It was postulated
that most of the substances are absorbed in the GI tract by a
passive diffusion upon transcellular and paracellular absorption
pathways, although some drugs have to be absorbed by carrier-
mediated transport according to their responses to membrane
permeability (Ho, 2011). For intestine delivery and absorption,
there is need to ensure stability of encapsulate and, especially of
bioactive material, within the gastric stage.
In general, the bioavailability of drugs is highly dependent
on fluctuations of GI pH values. The intraluminal pH varies
along the GI tract, from very acidic in the stomach (lowest
values in digesting phase are 1–2 and about 4–5 during the
resting phase) to neutral in the large intestine; pH values
increase up to 5.5 in the upper small intestine, reach the
maximum of 7.5 in the ileocolonic region, then decrease to
5.7 in the cecum, and increase again to pH of ∼6.7 in the
rectum (Maurer et al., 2015). It could be assumed that GI
absorption of different EOs constituents will follow pH partition
theory, via passive transport of lipophilic, unionized compounds
through biological membranes (Maderuelo et al., 2019). The
pH of the stomach as being acidic favors the absorption of
weak acids, whereas the pH of the small bowel, being closer
to neutrality, facilitates the absorption of weak bases, as stated
by Abuhelwa et al. (2017). It is thought that alcohols (and
hence the terpene alcohols) act as both weak acids and weak
bases, depending on factors, such as electronegativity, inductive
and resonance effects and polarizability, as well as salvation
as an extrinsic factor (Roberts and Caserio, 1977). In that
sense, it could be expected that terpene alcohols, such as citral,
linalool, geraniol, 1,8-cineole, and so on, might behave either
as acids or as bases, depending on microenvironmental GIT
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conditions, in the first pH, which will much influence their
absorption site. On the other hand, terpenes with a carboxylic
group (e.g., carnosic acid, abietic acid) and phenolic terpenes
(e.g., thymol, anethol, carvacrol) usually behave as weak acids
and thus might be absorbed in the stomach, at least partially.
Finally, N-containing terpenes, mainly derivatives of amino
acids other than L-phenylalanine and aminated terpenes, might
act as a weak bases as will be more readily absorbed in the
intestine. However, the absorption mechanisms are much more
complex and cannot simply follow the pH partition theory,
due to different intermolecule interactions, changes in molecule
structure under different conditions of GI tract, and special
features of each individual body. Therefore, it is pretty difficult
to predict the bioavailability of particular EOs constituent only
upon its physicochemical properties, such as molecular mass,
functional group, stability, solubility, responses to pH, and so
on. These data are insufficiently informative for speculations on
interactions of EOs with a range of biomolecules in such complex
biological systems, as tissues and organs of a human body.
Metabolism, Distribution, and Excretion
To enhance bioavailability, the bioactive compound should
exhibit sufficient absorption and low (renal) clearance, i.e.,
excretion ability. As soon as an EO component comes in the
bloodstream, the body begins to modify it, i.e., to break it into
the smaller and more polar molecules for easier kidney filtration
and elimination (Djilani and Dicko, 2012).
Liver metabolism includes transformation processes of
oxidation and hydroxylation, as well as adding of some polar
accessories, known as phase I (metabolism via the cytochrome
P450 path) and phase II (glucuronidation, sulfation, and
glutathione conjugation), respectively. Metabolic fate is highly
dependent on the chemical nature of EOs and their individual
compounds. Essential oil metabolites of phase II were found
in human and animals, in form of glucoronides and sulfates,
whereas excreted metabolites are mainly glycine and glucuronic
acid or are exhaled as CO2 (Kohlert et al., 2002). Terpenes are
distributed from blood circulation to other tissues. Because of
high clearance and short elimination half-life, their accumulation
is doubtful. It was shown that, after oral administration of
menthol, 35% of the original amount of the compound was
excreted renally as menthol glucuronide, the major biliary
metabolite able to enter enterohepatic circulation (e.g., Kohlert
et al., 2000; Grigoleit and Grigoleit, 2005). The similar was
reported for thymol, carvacrol, limonene, and eugenol. After oral
intake of EOs, sulfate and glucuronide metabolites have been
found in urine and in plasma, respectively (Guénette et al., 2007;
Michiels et al., 2008).
Lipophilic substances, such as EO components, are able to
penetrate the blood–brain barrier and to interact with various
brain receptors, such as γ-aminobutyric acid and glutamate
receptors (Tisserand and Young, 2014). Monoterpenes and
sesquiterpenes would be expected to spend a short time in
the bloodstream before being redistributed first to muscle and
then over a longer period to fat (Tisserand and Young, 2014).
However, it is known that EO compounds are easily absorbed,
and only a small portion of the EO remains unchanged (e.g.,
Kohlert et al., 2000; Djilani and Dicko, 2012), independently
on administration route. The fast metabolism and short half-
life of active compounds of EOs ensure minimum risk of their
accumulation in body tissues (Kohlert et al., 2002).
Characteristic and distinctive properties of EOs and their
constituents relating their physicochemical characteristics,
bioavailability, and especially biological effects at the target site
are a crucial point for the determination of appropriate carrier
system and related encapsulation technique.
NEEDS FOR MICROENCAPSULATION OF
EOs: ENCAPSULATION TECHNOLOGIES
AND SELECTION OF CARRIER SYSTEMS
Microencapsulation of active compounds, including EOs,
has two functions: (1) to enhance the oxidative stability,
thermostability, photostability, shelf life, and biological activity
and (2) to ensure their target delivery (Gallardo et al., 2013; Yang
and McClements, 2013; Martins et al., 2014; Xiao et al., 2014;
Yang et al., 2015). Specifically, encapsulation of EOs controls
the volatility, sensory (mainly odor and taste), and release
properties of EOs and ensures the prolonged chemical stability
and biological activity under storage conditions (e.g., Bilia et al.,
2014).
Several reviews pointed out that the bioactivity of EOs
is improved by encapsulation (e.g., van Vuuren et al., 2010;
Bilia et al., 2014; Dima et al., 2014; Asbahani et al., 2015; Li
et al., 2015; Pandit et al., 2016; Maderuelo et al., 2019). For
example, encapsulated peppermint oil in starch-based emulsions
exhibited increased bioavailability and stability characteristics
and enhanced activity against Listeria monocytogenes and
Staphylococcus aureus compared to free EO (Liang et al., 2012).
It was shown that the antibacterial activity of EOs after their
nanoencapsulation very often succeeded to surpass the efficiency
of current antibiotic (Zaman et al., 2017).
The enhancement of the biological activity of encapsulated
EO could be primarily attributed to better stability and reduced
exposure to degradation processes by entrapping. However, it
was hypothesized that in some cases such effects are a result
of synergistic effects by interactions of EOs with some carrier
materials, such as cashew gum or chitosan (e.g., Pandit et al.,
2016). Finally, the encapsulation in nanometric particles per se
contributes to better cellular absorption mechanisms and the
bioefficacy (Bilia et al., 2014).
The stability, release kinetics, and related bioavailability
and bioactivity of encapsulated material are highly dependent
on encapsulation technology. Several encapsulation techniques,
such as spray drying, extrusion, coacervation, emulsification,
and so on, are used today for encapsulation of EOs (Figure 3),
depending on main features of core material and the carrier,
as well as application of encapsulated material. Spray drying
is a rapid, continuous, relatively low-cost production operation
and easy production scale-up. Biomolecules applied as carriers
for the spray-drying technique are maltodextrins, starch, gum
Arabic, and chitosan (Ersus and Yurdagel, 2007; Kausadikar
et al., 2015). Disadvantages of spray-drying technique in general
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FIGURE 3 | Different techniques for EO encapsulation.
are as follows: (1) non-uniform particles size and shape, (2)
tendency of particles to aggregate, (3) carrier material solubility
in water at an acceptable level, and (4) short-time exposure to
high temperatures.
Coacervation could be suitable technique for covering EO
droplets by single shell (simple coacervation) or two-layer
shell (complex coacervation). Shell material should ensure (1)
rigidity of oil carrier, (2) thermal stability, and (3) chemical
stability under gastric condition and (4) should be dissolved
in intestine fluid. Two-layer shell consists of inner layer near
the oil droplets and outer layer. Inner layer can be made from
amphiphilic materials, such as proteins or some surfactants
(Torcello-Gomez et al., 2011). Outer layer usually consists
of polysaccharide hydrogels suitable to ensure mechanical
stability of oil carriers and satisfy proposed process conditions.
Extrusion is the technique that can be used in combination
with coacervation. This technique is suitable for preparing (1)
polysaccharide monophase and multiphase hydrogel matrices,
and (2) polysaccharide–protein hydrogel blends in the form of
microbeads (Nedović et al., 2011; Volić et al., 2018; Obradovic
et al., 2019). The advantages of extrusion are (1) the chemical
stability of beads under storage conditions and gastric conditions,
(2) the mechanical stability of the beads, and (3) the possibility of
encapsulation of hydrophobic or hydrophilic active compounds.
The disadvantages of this technique could be (1) low production
rate and (2) scale-up difficulties (Gouin, 2004). Another
frequently used technique is emulsification. Emulsions, such as
vegetable oils with addition of proteins and emulsifiers represent
a good choice as carriers for encapsulation of hydrophobic active
compounds. Emulsification technique is suitable for preparing
the small-sized particles (10 µm−1mm) compared with the
extrusion technique. However, processing costs seem to be higher
than for extrusion.
The choice of carrier material for oral administration depends
on (1) the surface activity of active compound, (2) processing
conditions, (3) storage conditions, and (4) cost and scale of
production. In the context of target delivery of carriers to
lower intestine, they should keep their integrity under gastric
conditions during retardation time. In order to optimize carrier’s
performance, it is necessary to consider (1) the interactions of
pepsin with the main constituents of carrier’s matrix at molecular
level and (2) carrier structure at supramolecular level.
Carriers, often used in the literature, could be classified into
two groups: (1) carriers made by natural macromolecules and (2)
lipid-based carriers. Carriers made by natural macromolecules
can be divided in few groups: (1) monophase polysaccharide
hydrogels, (2) multiphase polysaccharide hydrogels in the form
of blends or multilayer microbeads, and (3) polysaccharide–
protein hydrogels in the form of blends, (4) lipid-based carriers,
such as some vegetable oils and liposomes, and (5) lipid–protein
carriers. Various polysaccharide ionic hydrogels, such as Ca–
alginate (Chan, 2011), alginate–cashew gum (de Oliveira et al.,
2014), cashew gum–inulin (de Barros Fernandes et al., 2016),
alginate–xanthan gum (Zhang S. et al., 2014), xanthan gum–
pectin (Qiu et al., 2015), alginate–pectin (Wang et al., 2013), and
alginate–chitosan (Xu et al., 2007), have been used as the carrier’s
matrix primarily for the entrapment of hydrophilic active
compounds, such as some types of polyphenols. Polysaccharide–
protein hydrogels are suitable for the entrapment of hydrophobic
active compounds, such as EOs and some types of polyphenols
because of the amphiphilic properties of proteins. Frequently
used proteins blended with alginate, pectin, and xanthan are
lupin (Piornos et al., 2017), soybean lecithin (Torcello-Gomez
et al., 2011), gliadin (Qiu et al., 2015), whey proteins (Zhang et al.,
2016), gelatin (Roy et al., 2009), and many others. Liposomes are
suitable for the encapsulation of hydrophilic and hydrophobic
active compounds (Akbarzadeh et al., 2013). Vegetable oils
reach by long-chain triglycerides are a good choice for the
encapsulation of EO because of their resistance to the action of
pepsin (Yara-Varon et al., 2017).
Polysaccharide-Based Carriers
Polysaccharides, such as alginate, chitosan, and maltodextrin,
are widely used in the form of physical or chemical hydrogels
for encapsulation of EOs (Ravichandran et al., 2014; Gomez-
Mascaraque et al., 2015; Pasukamonset et al., 2016). Alginate is
a common name for a whole family of natural, water-soluble,
linear macromolecules of high molecular mass (between 32,000
and 400,000 g/mol) primarily extracted from brown algae species.
The distribution of mannuronic acid and guluronic acid units
in alginate chain containing blocks of G-G, M-M, and M-G
residues [where G is α-L-gluronic acid, andM is β-D-mannuronic
acid Milivojevic et al., 2015], as well as their ratio (M/G),
depends on the natural source of alginate (type of algae, season,
location etc.) and predominately determine their physical and
chemical properties. Chitosan is composedmainly of (1, 4) linked
2-amino-2-deoxy-D-glucan. Similarly as alginate, the chitosan
chains also behave as semiflexible chains. Anion-like alginate
chains spontaneously form gel with cation-like chitosan chains
at pH 7.0 with various rheological behavior, depending on the
alginate-to-chitosan ratio. Maltodextrin is extracted from starch
by partial hydrolysis. This type of polysaccharide consists of
D-glucose units connected in chains of variable length.
Ca–alginate has been proposed in order to improve
bioavailability, thermal stability, and biological activity of active
compounds under simulated GI conditions (Cho et al., 2014;
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Pasukamonset et al., 2016). However, undesirable leakage of
EOs could be resulted by weak interactions between active
compounds and hydrogel matrix. In order to improve the carriers
performances, Ca–alginate beads could be coated with chitosan.
The additional stability of carriers is provided by formation of
alginate–chitosan complexes (Popa et al., 2000; Anbinder et al.,
2011). Devi and Maji (2009) used chitosan–carrageenan carriers
to encapsulate neem EO. Neem seed oil is a commercialized
product derived from fruits of the neem tree, also named
margosa oil. Microencapsulation of pimento EO in chitosan
and k-carrageenan ensures antimicrobial activity against various
bacteria, such as Candida utilis, Bacillus cereus, and Bacillus
subtilis (Dima et al., 2014). Dong et al. (2011) used gum Arabic
as carriers for microencapsulation of peppermint EO. Prolonged
release of peppermint EO (and its major compounds, mainly
menthol and isomenthol) is ensured by encapsulation (Sarkar
et al., 2013).
Maltodextrin is a hydrolyzed starch commonly used for
microencapsulation of EOs in combination with surface active
biopolymers, such as gum Arabic (Fernandes et al., 2008;
Bule et al., 2010; Kausadikar et al., 2015), modified starches
(Bule et al., 2010), and proteins (Hogan et al., 2003; Bae and
Lee, 2008) in order to ensure an effective encapsulation by
spray drying process. It is in accordance with the fact that
maltodextrin provides good thermal stability and protection
against oxidation. However, this polysaccharide ensures low
emulsifying capacity. Consequently, it is desirable to mix
maltodextrin with surface-active biopolymers in order to advance
the volatile retention of bioactive compounds during the
drying process (Ersus and Yurdagel, 2007; Fang and Bhandari,
2010; Paz et al., 2010; Mahadivi et al., 2016; Tolun et al.,
2016). Composite made by gum Arabic, modified starch,
and maltodextrin has been used for microencapsulation of
cardamom EO in order to increase the stability of components,
such as 1,8-cineole and α-terpinyl acetate (Krishnan et al.,
2005). Kanakdande et al. (2007) used similar carriers for
microencapsulation of cumin oleoresin. They reported that
cumin volatile EO consists of terpenes (such as β-pinene,
p-cymene, and γ-terpinene), aldehydes (cuminaldehyde, 1,3-
pmentha, and 3-p-menthen-7-al), and terpene alcohol. Oxygen
barrier properties of maltodextrin depend on the dextrose
equivalent (DE). Carriers with higher DE ensure intensive
interactions between active compounds and matrix, which
ensure higher encapsulation efficiencies. These carriers are less
permeable to oxygen.
Maltodextrin with high DE has been successfully utilized in
the encapsulation of lemon EO, orange peel EO, cardamom
EO, and ginger EO to protect it from oxidation (Touré
et al., 2011; Simon-Brown et al., 2016). Recently, it was
shown that maltodextrin as carrier material has also an
ability to provide protection of the polyphenol compounds
against enzyme actions in simulated GI conditions (Romano
et al., 2017). The xanthan gum, an extracellular microbial
polysaccharide, has been used as a carrier for antioxidants and
phenolic compounds (Da Rosa et al., 2013; Rutz et al., 2013).
Xanthan gum has potential to be used as a carrier material in
combination with maltodextrin and chitosan in order to ensure
strong electrostatic interactions, between the amino groups of
chitosan (polycation) and the carboxylic groups of xanthan
(polyanion). This type of blend carriers has demonstrated
improvement in the controlled release rate of encapsulated
ingredient (Martínez-Ruvalcaba et al., 2007; Da Rosa et al.,
2013). It was also reported that the biopolymer complexes of
xanthan gum and whey proteins have emulsifying power and
also the positive effect on the control release of water-soluble
nutraceuticals in the delivery systems type of W/O/W double
emulsions (Benichou et al., 2007; Prichapan and Klinkesorn,
2014).
Protein-Based Carriers
Proteins as natural food-grade polymers were used: (1) alone
and (2) in combination with polysaccharide hydrogel as carrier
materials for microencapsulation of many EOs, because of
their binding hydrophobic interactions and hydrogen bonding
attraction between molecules (Zou et al., 2012; Haratifar
and Corredig, 2014; Chuacharoen and Sabliov, 2016). Protein
interchain and intrachain self-cross-linking is prerequisite in
formation of protein carrier matrix. This crosslinking could be
induced in some cases by heat treatment or by changing the
pH of a solution (Shpigelman et al., 2010; Tavares et al., 2014).
Protein-based carriers, such as gelatin, casein, whey proteins,
and soy proteins, have been mostly used for encapsulation
of thermosensitive, hydrophobic bioactive compounds (Pool
et al., 2013; Xue et al., 2014; Jia et al., 2016). Encapsulation
efficiency of these carriers depends on binding affinity of
the polyphenols and EOs to protein matrix (Livney, 2010).
Release property of bioactive compounds from the protein-
based carriers depends on pH conditions. Pronounced swelling
of protein-based carriers obtained at neutral pH could induce
the undesirable leakage of bioactive compounds (Kimpel and
Schmitt, 2015; Liu et al., 2015). Important disadvantage
of this type of carriers is significant disintegration under
gastric condition caused by pepsin attack (Kumar et al.,
2016). Sutaphanit and Chitprasert (2014) used gelatin for
microencapsulation of basil EO. Its main components include
methyl eugenol (42.58%) followed by caryophyllene (26.88%)
and eugenol (10.66%).
Compared to protein-based carriers, combination of
protein–polysaccharide carriers can improve mechanical and
release properties of the delivery systems and prevent the
enzymatic degradation of the proteins in gastric condition
(Diaz-Bandera et al., 2013; Jia et al., 2016). In addition,
many studies have shown that globular proteins, as well as
whey proteins hydrolysates, have antioxidant activity. They
can reduce the undesirable oxidation of EOs and provide
better oxidative stability of the carriers (Dryakova et al.,
2010; Carneiro et al., 2013). The protein–polysaccharide
carriers are excellent systems for encapsulation of EOs
in order to (1) stabilize these active compounds and (2)
protect them from chemical degradation (Turasan et al.,
2015; Campelo et al., 2017). Oregano EO emulsion was
stabilized by Tween 80 and encapsulated in various types of
microcarriers, such as milk powder and whey protein particles,
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rice starch particles and inulin, and gelatin–sucrose composite
(Beirãao da Costa et al., 2012).
Advantage of polysaccharide carriers is in nutrition
quality, easy preparation procedure, and low cost. The
disadvantage is related to low encapsulation efficiency,
loading capacity, and release efficiency in small intestine
(de Oliveira et al., 2014). Addition of protein clusters improves
their thermal and mechanical stabilities and nutrition quality.
The disadvantage of polysaccharide/protein carriers for
encapsulation of EOs is also related to low encapsulation
efficiency, loading capacity, and release efficiency in
small intestine (Dajić Stevanović et al., 2018; Volić et al.,
2018).
Lipid-Based Carriers
Lipid-based carriers made by vegetable oils have been widely
used for encapsulation of EOs (Bilia et al., 2014). The
main advantages of these carriers are (1) good encapsulation
efficiency, (2) stability of active compounds under storage
conditions and under gastric condition, and (3) thermal stability
(Campos et al., 2014). Vegetable oils represent a mixture
of triglycerides (major components) and minor components
(<5%), such as glycerolipids, such as monoglycerides and
diglycerides, phospholipids, and non-glycerolipids, including
sterols, tocopherols/tocotrienols, free fatty acids, vitamins,
pigments, proteins, phenolic compounds, water, and so on (Yara-
Varon et al., 2017).
Other types of lipid-based particles are liposomes and solid
lipid carriers. This type of the carriers can be used for
encapsulation of hydrophobic, hydrophilic, and amphiphilic
molecules (Yoshida et al., 2010). The thin film hydration, freeze–
thaw, sonication, and reverse-phase evaporation were mostly
used methods for their preparation and encapsulation of EOs.
The disadvantages of liposomes are: (1) complex and expensive
preparation procedure and (2) reduced stability under storage
conditions that could restrict their applications (Akbarzadeh
et al., 2013). Solid lipid nanoparticles and nanostructured
lipid carriers were used as nanocarriers for the delivering of
polyphenol-type catechins (EGCG) (Shi et al., 2013).
Lipid carriers can be combined with proteins in order to
improve their chemical and mechanical stabilities, as well as
encapsulation efficiency. Carriersmade bymixing of proteins and
lipid components (β-lactoglobulin-medium chain triglyceride)
have been successfully used for the encapsulation of polyphenols
(Pool et al., 2013).
Advantages of lipid carriers are higher encapsulation
efficiency, loading capacity, and release efficiency in small
intestine in comparison with polysaccharide/protein carriers.
However, the disadvantage is related to low mechanical and
thermal stabilities, which significantly reduce their usefulness,
as well as complex preparation procedure, and higher cost in
comparison with polysaccharide/protein carriers (Akbarzadeh
et al., 2013).
Examples of combined carriers for encapsulation of EOs are
provided in Table 3, whereas main challenges in choice of carrier
systems for EO encapsulation are illustrated in Figure 4.
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Chemical Stability of Carriers Under
Gastric Conditions
Chemical stability of carrier matrices under gastric condition is
considered at molecular level and supramolecular level in order
to improve their resistance to the attack of pepsin. Affinity and
activity of pepsin to the various components of carrier’s matrix,
such as polysaccharides and proteins under gastric condition,
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FIGURE 4 | Challenges in carrier selection for EO encapsulation.
are considered at molecular level in the context of various
physical and chemical factors. The structural changes of carrier’s
matrix represent the cumulative effects of pepsin interactions
with the carrier’s components and could lead to undesirable
carrier weakening and the leakage of active compounds. Deeper
understanding of these structural changes is necessary in order to
improve the carrier’s performances.
Affinity and Activity of Pepsin
Pepsin is the one of the aspartic protease enzymes. All members
of this class of enzymes have two aspartic acid residues within
their structure that act as the active site. Pepsin could not form
chemical bonds with biopolymers. The mechanism of pepsin
action is related to the ability of the two aspartic acids at the
reaction site to simultaneously act as both an acid and a base.
Affinity and activity of pepsin to biopolymers, such as
polysaccharides and proteins under gastric conditions depend
on chemical and physical factors. The physical factors of
biopolymers are (1) isoelectric point; (2) the surface activity of
biopolymer; (3) the flexibility of chains; (4) the conformation
of chains under gastric condition, which is related to its
hydrophobic/hydrophilic behavior; and (5) chain length.
Chemical factors are related to (1) possible pepsin attack to
biopolymers and (2) possible pepsin inactivation caused by the
presence of biopolymers. Pepsin attack is directed to glycoside
bonds (characteristic for polysaccharides) and the peptide
bonds of aromatic amino acids, such as tryptophan, tyrosine,
phenylalanine, and glutamate (characteristic for proteins).
Pepsin inactivation is induced primarily by carboxyl groups and
hydroxyl groups of biopolymers.
Polysaccharides rich by carboxyl groups, such as alginate,
maltodextrin, and pectin, can inactivate pepsin (Strugala
et al., 2005). At the same time, pepsin can hydrolyze these
polysaccharide chains. The efficiency of hydrolyze depends
on (1) the number of glycoside bonds, which correlates with
chain length, (2) the flexibility of chains, and (3) branching of
polysaccharide chains. Mannuronic acid is more flexible and
more reactive with pepsin than guluronic acid (Chater et al.,
2015). Polysaccharides, such as xanthan gum have rigid rod-
like chains, which are more resistant to pepsin attack. Branched
polysaccharides, such as maltodextrin are more resistant to
pepsin attack than unbranched polysaccharide, such as alginate.
Pepsin–polysaccharide interactions depend on the charge of
polysaccharide under gastric conditions. Interactions between
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pepsin and polysaccharide molecules are more intensive for
molecules with lower value of the isoelectric point. The isoelectric
point of (1) xanthan gum is 2.8 (Souza et al., 2013), (2) α-L-
gluronic acid is 3.65, (3) β-D-mannuronic acid is 3.38 (Draget
et al., 1996), and (4) chitosan is 5.14 (Kalliola et al., 2017).
Consequently, short-chain chitosan is more resistant to pepsin
attack than alginate because of the higher value of isoelectric
point (Boeris et al., 2011). Short chains correspond to lower
amount of glycoside bonds per chain, which is desirable.
Efficiency of pepsin attack to proteins depends on (1)
their hydrophilic-to-hydrophobic ratio, (2) isoelectric point,
(3) the conformation of chains, and (4) interrelation between
the mentioned factors under gastric condition. More open
conformations enable pepsin attack to aromatic amino acids.
β-Lactoglobulin, the major constituent of whey protein, is
resistant to pepsin attack in its native form because of its
close conformation and low hydrophilic-to-hydrophobic ratio
(Lorieau et al., 2018). Contrary, casein and soybean proteins are
more reactive with pepsin (Cui et al., 2013; Lorieau et al., 2018).
Carriers Disintegration Under Gastric
Conditions
Lipid carriers represent the best choice in order to keep entrapped
active compounds out from the attack of pepsin. Vegetable oils
are suitable for the entrapment of EOs, whereas liposomes could
be used for immobilization of both hydrophilic and hydrophobic
active compounds. Vegetable oils rich by long-chain triglycerides,
such as corn oil, nut oil, and canola oil are more suitable because
of small digestion rate and resistance to pepsin attack (Majeed
et al., 2015).
Polysaccharide hydrogels and polysaccharide–protein
composites in the form of microbeads have been widely
used for the entrapment of hydrophilic compounds, whereas
polysaccharide–protein microbeads have been used for the
entrapment of hydrophobic compounds. It is in accordance
with the advantage of these carriers, such as (1) easy and cheap
preparation procedure and (2) stability under storage conditions
in dry state. Ca–alginate have been frequently used for various
applications compared with other polysaccharide hydrogels.
However, pepsin can easily diffuse through porous structure of
amorphous hydrogels and disintegrate them. Hydrodynamic
radius of pepsin is 3 nm (Gtari et al., 2017), whereas the average
pore size of ionic polysaccharide hydrogel, such as Ca–alginate
is in the range from 10 to 20 nm (Funueanu et al., 1999).
Diffusion time corresponds to the minute time scale. Grunwald
(1989) reported that the internal diffusion of small molecules,
such as glucose within 2% Ca–alginate beads was equilibrated
during 3min for a corresponding bead radius of 1.53mm and
during 8min for corresponding bead radius of 3.20mm at
room temperature.
The process of hydrogel disintegration is much faster than
the process of pepsin inactivation by alginate chains. Pepsin
inactivation by alginate chains corresponds to the several tens of
minutes to hours’ time scale (Koutina et al., 2018). The process
of hydrogel disintegration corresponds to the diffusion time. In
order to improve its stability under gastric condition, Ca–alginate
beads have been coated by low-viscosity chitosan (Huguet and
Dellacherie, 1996). This is an efficient way to keep hydrophilic
active compounds under gastric condition and ensure their
transport to low intestine. The blending of Ca–alginate with whey
proteins (Zhang S. et al., 2014) improves carriers’ resistance to
pepsin under gastric condition. Polysaccharide–protein hydrogel
carriers consist of (1) polysaccharide phase, which represents the
continuum, and (2) dispersed phase, which consists of partially
connected protein clusters. Interactions between proteins and
polysaccharides at the interface are primarily electrostatic
repulsive. The mechanical behavior of these carriers could
be understood in the context of two opposite tendencies.
Protein clusters are stiffer than surrounding polysaccharide
hydrogel. It could be expected that protein addition induces
the reinforcement of the carriers. However, both of them are
positively charged under gastric condition. Electrostatic repulsive
interactions between polysaccharide and protein chains at the
interface could induce the weakening of the beads, depending on
polysaccharide-to-protein mass ratio.
In summary, most polymeric and oligomeric wrapping
structures serving as EOs carriers, such as proteins and
carbohydrates, break down by acidic conditions of the gastric
phase (Wood, 2005). Digestion rate is directly dependent on
the droplet size (Salvia-Trujillo and McClements, 2016), but
adversely related to viscosity of dispersion (Ahmad et al., 2018).
Some materials are resistant to gastric digestion (e.g., cellulose
and cellulose derivates, resistant starch, some pectins and
alginates, etc.) and serve for release of active compounds in
the colon, being exposed to subsequent microbial degradation
(Belali et al., 2019). Many reports stressed that gut microbial
transformation could potentially improve the therapeutic effects
of plant bioactive products, including EOs and particular
terpenoids (Wang et al., 2019).
In general, the choice of appropriate carrier system and
encapsulation technology should be dependent on (1) active
ingredient/carrier interaction, (2) bioavailability of the both
internal (the active) and the external phase (shell material), (3)
release and bioactivity of the active phase at the target site, (4)
application needs (e.g., medicine, food, agriculture), (5) safety
issues (related to administration route), and (6) sustainability of
the entire encapsulation process and economy-based aspects.
BIOMEDICAL APPLICATION OF
ENCAPSULATED EOs AND DEPENDENCE
ON ADMINISTRATION ROUTE
Because of potent biological activity and general low genotoxicity
and cytotoxicity, the application of EOs in pharmaceutical and
cosmetic industry is rapidly increased globally, especially because
of expressed multidrug, especially antibiotic resistance, and
achievements in drug delivery technologies. Encapsulated EOs
or their constituents are used in the form of microparticles and
nanoparticles, upon the desired biodegradability of a carrier and
projected action site of the active substance.
Topical application of both free and encapsulated EOs is
considered as generally safe. Dermal application ofmicroparticles
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and especially nanoparticles allows the penetration of the active
substance into the deeper skin layers providing its sustained and
slow release (Bilia et al., 2014). Additional benefits of dermal
administration of EOs are that many EO components act as skin
penetration enhancers simultaneously exhibiting fast metabolism
and excretion rates upon topic application (Herman and
Herman, 2014). It was shown that nanoparticles could be used
as topical delivery systems for skin cancer treatment (Arpagaus
et al., 2018) or as wound healing and skin anti-inflammatory and
antiaging agents recently considered as cosmeceuticals (Carvalho
et al., 2016). High penetration ability and hydrophobic features of
EOs are suitable for their encapsulation in lipid emulsion systems
and lipid-based carriers, mainly liposomes that are widely used in
dermatology and cosmetics.
Through oral and respiratory route, the delivery systems
encounter the mucosal lining of the GI tract and lung,
respectively. Therefore, to ensure the target delivery and reaching
the action site, the encapsulate should be able to adhere to
the mucus, which would enhance the drug absorption and
facilitate its transport across the epithelium (Bilia et al., 2014).
Because the mucosal surface is negatively charged, the positively
charged carriers, such as chitosan, seem to be the most effective
(e.g., Kalliola et al., 2017). Furthermore, chitosan is a suitable
carrier for mucosal delivery because of low toxicity, good
biodegradability, and antibacterial activity (e.g., Kim et al.,
2003), in addition to a respiratory application of mannitol,
leucine, lactose, and trehalose used because of their high aqueous
solubility and low toxicity (Arpagaus et al., 2018).
In regard to achieving the efficient delivery of the active
compound into the deep lung regions, the particle size should
be designed at 1 to 5µm, allowing penetration and deposition
in the alveolar regions (Arpagaus et al., 2018). The larger
particles might be deposited in the throat, whereas the smaller
ones are exhaled. It could be expected that application of
inhalable EO encapsulated products will increase in the future
because of already developed systems for pulmonary drug
delivery, including nanoparticles, microparticles (microspheres),
solid lipid nanoparticles, and lipid vesicles, such as liposomes
(Mehta et al., 2020). It is well-postulated that EOs and their
constituents have strong effects on mitigation and healing of
many respiratory diseases and disorders (e.g., Horváth and
Ács, 2015), so it could be expected that encapsulated inhalable
EOs will be favorized over non-encapsulated drugs, because of
enhanced bioavailability, better stability, adjustment of dose and
optimization of particle size and morphology, and release and
lung deposition characteristics.
The biomedical application of encapsulated EOs for oral
administration is currently less represented than use in products
for human and animal nutrition. However, there are strong
benefits of oral intake of encapsulated EOs, referring to great
possibility to select the adequate combination of active substance
and the prominent biodegradable, edible, and stable carrier for
enhanced bioavailability and target site activity. Depending on
a goal and the target mode of action, the selection of carrier
system would include those sensitive to stomach, the intestine, or
colon degradation, as particular EOs exhibit favorable activities
at the different final deposition places. The wall materials used
for the oral administration of encapsulated EOs should include
water-soluble, edible, non-irritant, and biodegradable polymers,
such as gelatin, chitosan, maltodextrin, sodium caseinate, pectin,
cellulose, gum arabic, alginate, and so on (Arpagaus et al., 2018),
and/or their combinations. In our opinion, there is a strong
prospect for oral administration of encapsulated EOs, especially
in their application against bacterial-caused GI inflammation
processes, irritable bowel syndrome, and gastric ulcer conditions.
Moreover, the oral intake of encapsulated EOs could be suitable
in prophylaxes and for general health improvement. The oral
administration of entrapped EOs is the most convenient, the
cheapest, and among the safest application routes.
Finally, the intravenous application of encapsulated products
is the most questionable administration route, because it is
the most delicate and the most risky in terms of safety
issues and possible side effects. Despite the fact on low
EO toxicity and high biological activity, there are not many
reports on their intravenous applications so far. However, the
nanoparticles have been already evaluated for the treatment of
some solid tumors via intravenous administration (Arpagaus
et al., 2018). There is a report on promising systemic delivery
of nanoencapsulated linalool in novel cancer therapeutic
applications (Han et al., 2016).
Because of enhanced biological ability as a consequence of
favorable surface ratio (e.g., Shishir et al., 2018), the nanoparticles
are expected to be the main vehicle for the target drug delivery.
Nevertheless, the particles at nanoscale exhibit a range of new
properties and functionalities of unpredictable effects in the
human organism due to potential to penetrate and accumulate
much deeper within the human body, thus causing some
undesired and untypical effects (De Souza Simões et al., 2017).
Another Areas for Application of
Encapsulated EOs
Apart from entrapment of EOs for target drug delivery,
there is wide current application and further possibility for
their use in agriculture and the food and textile industry.
Upon recent information, the encapsulated EOs and their
individual constituents are used in agriculture, mostly as natural
pesticides (e.g., Bakry et al., 2016; Kumar et al., 2019) and
phytogenic feed additives (e.g., Dajić Stevanović et al., 2018),
because of their antibacterial, antifungal, and insecticidal effects.
Because of strong antimicrobial activity and expressed fragrance,
encapsulated EOs are used in home textiles and personal care
products, as well as in production of functional and fragrant
textile products (e.g., Bakry et al., 2016).
The application of encapsulated EOs and their constituents
is in evident expansion in industry of functional foods and
beverages (e.g., Gomez-Mascaraque et al., 2015; Ye et al., 2018;
Dima et al., 2020), natural food preservatives and additives
(Stratulat et al., 2014; Bakry et al., 2016), and in production of
active food packaging as incorporation of these active additives
in polymer matrices results in extended food shelf life (Ribeiro-
Santos et al., 2017).
There are many-fold benefits of encapsulated EO products
application in biomedicine, cosmetics, agriculture, and food
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and textile industry, referring to enhanced functionality and
bioctivity, prolonged shelf life, improved sensory characteristics,
increase of systemic activity, and novelty and innovations.
However, the main challenges in wider application of such
products are the following: safety and regulation issues,
achievement of stability and solubility of the active compound, its
integration and interfering with other components of a product,
possible development of multicapsulation systems for better
performances, and the industrial scale-up and high production
costs. Finally, there is a need for implementation of green and
sustainable technologies in fabrication of encapsulated products.
SUSTAINABLE PRODUCTION OF CARRIER
SYSTEMS FOR EO ENCAPSULATION
Modern processing biotechnologies should meet the sustainable
development requirements and drive industrial competition
toward more profitable and innovative way. The original
strategies and non-conventional encapsulation methods should
address the Green processing concepts (Vinceković et al., 2017),
including possibility of reuse and recycling of materials used in
encapsulation processes.
Agro-wastes are potential source for recycling
polysaccharides, proteins, and lipids and comprise the food
wastes and agricultural residues, such as peels and skins, unripe
or damaged fruits, seeds, husks, exhausted pulps, and other
material. Among the most interesting agro-waste residues as
possible polysaccharide sources, the sugarcane and cassava
bagasse, the corn stover and straw of corn, oats, wheat, rice, and
sorghum may be stressed (Di Donato et al., 2014).
Natural polysaccharides are widely used as a component
of carrier matrix applied for various biomedical applications,
primarily because of their biocompatibility, ability to form
hydrogels, and good mechanical and chemical stability. Pectin,
inulin, cellulose, starch, and starch’s maltodextrin are frequently
used carriers for EOs. Natural polysaccharides for EO carriers
are often obtained from wastes of vegetable industrial processing
by applying various chemical and enzymatic techniques (Poli
et al., 2011). Pectin might be extracted from different waste
materials, primarily from the apple pomace, the peel and other
by-products of citrus fruit production, and from cherry pomace,
pear waste, coffee husk, banana peel, black currant waste, and
carrot residues (Di Donato et al., 2014). Inulin is obtained
from inulin-rich vegetables and their residues, mainly from
leek, onion, garlic, and asparagus, whereas the most common
sources are tubers of Jerusalem artichoke and dahlia, in addition
to chicory roots (Singh and Singh, 2010). Starch itself is an
important carrier for EO encapsulation, which can be obtained
from different agro-waste material, such as corn fiber, corn bran,
potato peel, and some others (Di Donato et al., 2014). Starch is the
only source for maltodextrin production, usually by performing
partial acidic or enzymatic hydrolysis. According to Fierascu
et al. (2019), high fiber waste of mango rind, broken rice, and
pineapple peel and core, as well as red fruits concentrates, are
sources of maltodextrin/glucose polymers, other carbohydrates,
and simple sugars.
Seaweeds are potential renewable resource of phycocolloids,
such as alginate, agar, and carrageenan, where the alginate
content may rich 50% of dry weight in some algae, as in Undaria
pinnatifida (Chee et al., 2011). Alginates are among the most
used carriers in encapsulation of bioactives, including EOs,
whose chemical structure and related properties differ between
genera (McHugh, 2003). Extraction steps focus on converting the
alginate to the soluble form of sodium alginate and include stages
of pre-extraction with hydrochloric acid, washing, filtration, and
neutralization with alkali (Hernandez-Carmona et al., 1999).
The shell and arthropod exoskeloton wastes are rich sources
of valuable products, such as calcium carbonate, proteins,
carotenoids, and especially chitin, known as the most abundant
biopolymer next to the cellulose (Muxika et al., 2017). Extraction
of chitin and chitosan requires chemical and fermentation
pretreatment processes and application of some intensification
techniques, such as ultrasonication and microwave radiation
(Suryawanshi et al., 2019).
Polysaccharide matrices are mixed with various proteins in
order to improve encapsulation efficiency, chemical stability
under gastric condition, and the mechanical stability.
Vegetable proteins, such as those extracted from abundant
rawmaterials (cereals and legumes) or agri-food by-products and
waste streams (oilseed meals), have been used as components
of carriers. Properties of extracted polymers highly depend
on isolation method and conditions. Various techniques for
the isolation of proteins, such as micellization technique,
alkaline extraction/isoelectric precipitation, ultrasound-assisted
extraction, and electroactivation technique and approaches
(enzyme-assisted extraction) have been discussed in order to
improve protein extraction yield and functionality (Spiegel et al.,
2013; Hadnadjev et al., 2017).
The animals’ tissues contain proteins that can be used as
carriers of bioactive compounds. The most common animal
proteins used in encapsulation are collagen, gelatin, and whey
proteins (Aspevik et al., 2017; Fathi et al., 2018; Shishir
et al., 2018). The meat industry produces significant amounts
of collagen waste. Collagen, either collagen fiber or collagen
hydrolysate, can be successfully used as a carrier of antioxidants
in the food industry or additives in cosmetic products (Mokrejs
et al., 2009). Gelatin is a biopolymer produced by partial
hydrolysis of collagen derived from animal skin. This type of
biomaterial from renewable sources has been frequently used for
encapsulation of different types of bioactive compounds (Fathi
et al., 2018; Shishir et al., 2018).
The dairy industry throughout the world is facing the
problem of disposal and utilization of whey. Production of
whey proteins by ultrafiltration and the use of whole whey
or whey permeate as a fermentation feedstock are possible
options to economically recover the valuable nutrients for
human food or animal feed. Whey proteins are well-known
for their high nutritional and various functional properties in
food products. The ability of whey proteins to form gels and
microcapsules without the use of severe heat treatment and
chemicals makes them an attractive material for controlled
delivery applications of bioactive compounds. The bioactive
agents (polyphenols, antioxidants, etc.) can be added after the
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protein denaturation process to minimize the destruction of
many of these heat-sensitive components (Wichchukit et al.,
2013). The current treatments in whey production rely on
application of membrane technologies, such as ultrafiltration,
nanofiltration, microfiltration, and inverse osmosis for obtaining
the whey powder and whey protein concentrate, demineralized
whey powder, and permeate powder (Nicolás et al., 2019).
Addition of whey proteins significantly enhances stability of
polysaccharide carriers against pepsin attack. Consequently, such
type of carrier is suitable for various applications in biomedicine
and food technology (Volić et al., 2018; Obradovic et al., 2019).
Finally, different reused vegetable oils could be used especially
FIGURE 5 | Strategy of choice for the optimal carrier performances of encapsulation of EOs for biomedical application and enhanced bioavailability. (A) hydrogel
bead, (B) monolayer capsule, (C) multilayer capsule, (D) composite bead, (E) liposome.
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for (nano)emulsion systems, such as sunflower or palm oil for
recovery of glycerol, triglycerides, and other lipid compounds
used for EO delivery (e.g., Maes et al., 2019), in addition to oils
extracted from seeds originating from agro-industrial waste, such
as, for example, grape, guava, melon, passion fruit, pumpkin,
soursop, and tomato seeds (Silva and da, 2014). In summary,
the use of new alternative sources obtained from agro-industrial
waste may serve as valuable matrix and carrier material for
different encapsulates in food, chemical, and pharmaceutical
industries, as was illustrated for encapsulation of EOs in light of
the entire EO encapsulation process concept (Figure 5).
CONCLUDING REMARKS
Encapsulation of EOs and their individual compounds is
necessary for their target delivery, because of low water solubility
and stability, high volatility, and some other unfavorable side
effects, such as odor, taste, and sometimes the toxicity. Essential
oil activity and toxicity are a result of different interactions
of its constituents, such as additivity, synergy, or antagonism.
Therefore, it is difficult to predict the overall activity of such
complex mixtures as EOs, especially relating their dose and
concentration, depending on toxicity effects, frequency of use,
and bioavailability. The encapsulation usually prevents the
delivery of an EO in the stomach caused by acidic pH and the
pepsin attack, but allows the release of the drug in the small
intestine. Encapsulation of EOs (1) enables controlled release
of bioactive compounds, (2) increases their water solubility and
stability, (3) improves the bioavailability and drug efficacy, and
(4) reduces eventual toxic effects. Encapsulation is prerequisite
of applying EOs in pharmaceutics industry, medicine, and
cosmetics, as well as in functional food production. Accordingly,
with the fact that EOs and their bioactive compounds exhibit
strong antimicrobial and antioxidant activity, there is an
increased interest for developing of carriers for delivery of EO-
based preservatives in food systems with enhanced chemical,
thermal, and oxidative stability. Optimal carriers should be
biodegradable, food-grade, and able to protect the EOs from
exposure to the surrounding environment prior to release. In
case of encapsulation of EOs and their bioavailability, lipid
carriers, such as liposomes and solid lipid nanocarriers, in
addition to protein–polysaccharide and lipid–protein mixture
carriers, should be considered. We would like to emphasize
the particular role of protein–polysaccharide hydrogel carriers
among others, from the standpoint of (1) the ability of
their production from waste materials, (2) simple and cheap
encapsulation techniques, (3) satisfied encapsulation efficiency,
and (4) good mechanical and chemical stabilities under various
in vivo process conditions. Finally, it is important to stress a
possibility and challenges in use of green biotechnologies, reuse,
and waste management practices for obtaining desirable natural
carrier macromolecules.
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Dajić Stevanović, Z., Bošnjak-Neumüller, J., Pajić-Lijaković, I., Raj, J., and
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